Connexion
S'inscrire
Réinitialiser le mot de passe
Publier & Distribuer
Solutions d'édition
Solutions de distribution
Thèmes
Architecture et design
Arts
Business et économie
Chimie
Chimie industrielle
Droit
Géosciences
Histoire
Informatique
Ingénierie
Intérêt général
Linguistique et sémiotique
Littérature
Mathématiques
Musique
Médecine
Pharmacie
Philosophie
Physique
Sciences bibliothécaires et de l'information, études du livre
Sciences des matériaux
Sciences du vivant
Sciences sociales
Sport et loisirs
Théologie et religion
Études classiques et du Proche-Orient ancient
Études culturelles
Études juives
Publications
Journaux
Livres
Comptes-rendus
Éditeurs
Blog
Contact
Chercher
EUR
USD
GBP
Français
English
Deutsch
Polski
Español
Français
Italiano
Panier
Home
Journaux
Radiology and Oncology
Édition 56 (2022): Edition 2 (June 2022)
Accès libre
Cervix-Online computer program: 27 years of hospital-based clinical registry for cervical cancer at the University Medical Centre Maribor
Vida Gavric Lovrec
Vida Gavric Lovrec
,
Darja Arko
Darja Arko
et
Iztok Takac
Iztok Takac
| 22 déc. 2021
Radiology and Oncology
Édition 56 (2022): Edition 2 (June 2022)
À propos de cet article
Article précédent
Article suivant
Résumé
Article
Figures et tableaux
Références
Auteurs
Articles dans cette édition
Aperçu
PDF
Citez
Partagez
Article Category:
Research Article
Publié en ligne:
22 déc. 2021
Pages:
198 - 207
Reçu:
13 sept. 2021
Accepté:
22 nov. 2021
DOI:
https://doi.org/10.2478/raon-2021-0054
© 2022 Vida Gavric Lovrec, Darja Arko, Iztok Takac, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Figure 1
General data. CT = chemotherapy; RT = radiotherapy
Figure 2
Medical history, clinical examination, clinical stage (preoperative International Federation of Gynecology and Obstetrics [FIGO] stage). AGC - neoplastic = atypical glandular cells - neoplastic; AGC-NOS = atypical glandular cells - not otherwise specified; AIS = adenocarcinoma in situ; AC = adenocarcinoma; ASC-US = atypical squamous cells - of undetermined significance; ASC-H = atypical squamous cells - cannot exclude HSIL; GIT = gastrointestinal tract; HGSIL = high grade squamous intraepithelial lesion; IUD = intrauterine device; IUS = intrauterine system; LGSIL = low grade squamous intraepithelial lesion; MLG-N = other malignant cells - inevaluable; MTOP = medical termination of pregnancy; N/A = not available; SCC = squamous cell carcinoma; SFM-NOS = suspicious for malignancy - not otherwise specified
Figure 3
Tests at initial examination. CEA = carcinoembryonic antigen; L = left; NAD = no evidence of disease; R = right; SCC = squamous cell carcinoma antigen
Figure 4
Treatment. CT = chemotherapy: DVT = deep vein thrombosis; G-CSF = granulocyte colony stimulating factor
Figure 5
Histopathology, International Federation of Gynecology and Obstetrics (FIGO) stage after definitive histology. L = left; R = right
Figure 6
Chemotherapy cycles. CEA = carcinoembryonic antigen; G-CSF = granulocyte colony stimulating factor; NAD = nothing abnormal detected; SCC = squamous cell carcinoma antigen
Figure 7
Follow-up form. TH = therapy; NAD = nothing abnormal detected; ASC-US = atypical squamous cells of undetermined significance; ASC-H = atypical squamous cells – cannot exclude HSIL; LGSIL = low-grade squamous intraepithelial lesion ; HGSIL = high grade squamous intraepithelial lesion; SCC = squamous cell carcinoma; AGC-NOS = atypical glandular cells not otherwise specified; AGC-neoplastic = atypical glandular cells, suspicious for AIS or cancer; AIS = adenocarcinoma in situ; AC = adenocarcinoma; SFM-NOS = suspicious for malignancy; MLG-N = malignancy; SCC = squamous cell carcinoma antigen; CEA = carcinoembryonic antigen; UTI = urinary tract infection
Aperçu